Patricia (Patty) Martin joined BioCrossroads as the president and CEO in July 2019. A former Eli Lilly and Company executive, she was the chief operating officer (COO) of Lilly Diabetes for seven years as well as served as Lilly’s Chief Diversity Officer (CDO) and Chief Alliance Officer (CAO). In her 25-year career at Lilly, she also had leadership roles that included strategy, clinical product development, and investor relations.
Martin’s background is a unique breadth of experience integrating science and business. As COO of Lilly Diabetes, she was part of a leadership team that established a vision and strategy that uniquely addressed the increased prevalence and diverse needs of people living with diabetes. During her tenure, Lilly Diabetes launched an unprecedented six new products in 18 months, increasing sales from $6 billion to $8 billion. As CAO, she spearheaded collaborative efforts to ensure the success of Lilly’s partnerships and facilitated cross-functional and cross-disciplinary cooperation to deliver results.
Martin serves on the board of directors of CareSource, Inc. and UltiMed, Inc.
Actively involved in Indianapolis and national non-profit organizations, she is currently a member of the Indiana University Women’s Philanthropy Leadership Council; member of the board of trustees of the Christian Theological Seminary; the Dean’s Advisory Council for the Indiana University Kelley School of Business; and was the board chair for the 500 Festival in 2016. She also serves a board member of the Diabetes Patient Advocacy Coalition.
A graduate of Indiana University, Martin also earned her MBA from the Harvard School of Business.